Leaderboards/HIV-related health complications and treatments

HIV-related health complications and treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Papers

Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease

Circulation Research|2024

97 cit.

Dyslipidaemia management in pregnant patients: a 2024 update

European Heart Journal Open|2024

58 cit.

Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infection

Nature Communications|2024

31 cit.

Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV

BMC Microbiology|2024

13 cit.

Sustained gut dysbiosis and intestinal inflammation show correlation with weight gain in person with chronic HIV infection on antiretroviral therapy

BMC Microbiology|2024

9 cit.

Clinical reality and challenges with familial hypercholesterolemia patients' management. 2024 results from the Regional Center for Rare Diseases (RCRD) Registry in Poland

International Journal of Cardiology|2024

4 cit.

Publication in The Journal of Immunology (2025) [3 citations, W4408140797]

The Journal of Immunology|2025

3 cit.

Cytokine and chemokine receptor profiles in adipose tissue vasculature unravel endothelial cell responses in HIV

Journal of Cellular Physiology|2024

2 cit.

Lipoprotein(a) and Other Risk Factors in Dyslipidemic Patients with and without Heart Failure.

Archives of Medical Science|2024

2 cit.

Publication in Translational Medicine Communications (2024) [1 citation, W4401907135]

Translational Medicine Communications|2024

1 cit.

Emerging Leaders

Drafting the new consensus

Papers

Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort

Infectious Diseases and Therapy|2023

53 cit.

Single-cell profiling reveals inflammatory polarization of human carotid versus femoral plaque leukocytes

JCI Insight|2023

40 cit.

Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens

Open Forum Infectious Diseases|2022

34 cit.

Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes

BMC Infectious Diseases|2023

22 cit.

1028. Real-World Use of Long-Acting Cabotegravir + Rilpivirine in People with HIV with Detectable Viral Loads at Initiation: Findings from the OPERA® Cohort

Open Forum Infectious Diseases|2023

20 cit.

Immune response to <scp>ART</scp> initiation in advanced <scp>HIV</scp> infection

HIV Medicine|2023

19 cit.

Association of Cumulative Viral Load With the Incidence of Hypertension and Diabetes in People With HIV

Hypertension|2022

11 cit.

1608. Real-World Effectiveness of Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Treatment-Experienced Individuals: Two Years of Data from the OPERA® Cohort

Open Forum Infectious Diseases|2023

10 cit.

Monocyte subsets, T cell activation profiles, and stroke in men and women: The Multi-Ethnic Study of Atherosclerosis and Cardiovascular Health Study

Atherosclerosis|2022

8 cit.

Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA Cohort

AIDS Research and Human Retroviruses|2023

7 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

Steven Grinspoon

Massachusetts General Hospital

Jens Lundgren

Centre of Excellence for Health, Immunity and Infections

David A. Cooper

Illinois Institute of Technology

Amy C. Justice

Yale University

James D. Neaton

University of Minnesota

Anthony S. Fauci

Georgetown University

Grace A. McComsey

University Hospitals of Cleveland

Richard A. Koup

Aaron Diamond AIDS Research Center

David D. Ho

Columbia University

Steven G. Deeks

University of California, San Francisco

Papers

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

Nature|1995

4.3k cit.

HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time

Science|1996

3.5k cit.

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

Journal of Virology|1994

2.5k cit.

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

AIDS|1998

2.4k cit.

Coronavirus Infections—More Than Just the Common Cold

JAMA|2020

2.3k cit.

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Proceedings of the National Academy of Sciences|1997

2k cit.

Decay characteristics of HIV-1-infected compartments during combination therapy

Nature|1997

1.9k cit.

Changes in thymic function with age and during the treatment of HIV infection

Nature|1998

1.9k cit.

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

Nature|1993

1.8k cit.

Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy

Science|1986

1.7k cit.

Reagents for HIV-related health complications and treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Loading Control Antibody Sampler Kit

#5142$509

View Evidence →

Cell Signaling TechnologyEvidence 67

IMP3 (D6U2N) Rabbit Monoclonal Antibody

#57145$161,351

View Evidence →

Cell Signaling TechnologyEvidence 67

Vimentin (D21H3) Rabbit Monoclonal Antibody (PE Conjugate)

#12020$465

View Evidence →

🌟 All-Time

Most validated

Beckman Coulter

HIV-1 core antigen-RD1

Anti-HIV-1 Core Antigen Antibody, Unconjugated

Cited in 7 papers

#6604665

View Evidence →

Cell Signaling TechnologyEvidence 67

Total RIP3 Matched Antibody Pair II

Cited in 5 papers

#19570$1,726

View Evidence →